Literature DB >> 32690447

Development of a take-home naloxone program at an urban academic emergency department.

Vidya Eswaran, Katherine C Allen, Daniel S Cruz, Patrick M Lank, Danielle M McCarthy, Howard S Kim.   

Abstract

OBJECTIVE: To describe the development of an ED-based take-home naloxone (THN) program in which naloxone kits are dispensed directly to patients during ED discharge. PRACTICE DESCRIPTION: Our THN program was carried out at an urban academic hospital in downtown Chicago, IL. The THN kits consisted of 3 vials of 0.4-mg naloxone and 3 sterile syringes and needles for intramuscular delivery. Any member of the ED team (e.g., physician, pharmacist, or nurse) could recommend naloxone dispensing for a patient; however only the treating ED physician served as the prescriber for record. The ED pharmacist provided bedside education on recognizing opioid overdose and administering naloxone. The naloxone kit was dispensed to the patient at no cost. PRACTICE INNOVATION: This ED pharmacist-led naloxone dispensing model bypasses barriers to naloxone filling and ensures that patients walk out of the emergency department with naloxone in hand. EVALUATION
METHODS: We report key metrics from the first 16 months of program implementation, including the number of ED visits for opioid overdose and THN kits dispensed. We further describe the key facilitators and barriers to program development.
RESULTS: Over 16 months, our emergency department had 669 unique visits for opioid overdose, and we dispensed 168 THN kits (10.5 per month). We are aware of at least 3 cases in which our THN kits were used to reverse opioid overdose. We faced key informational barriers to program development, such as a lack of knowledge regarding the allowability of ED medication dispensing, as well as financial barriers, such as the need to obtain a supply of naloxone. We also recognized the key facilitators of success, such as early engagement with hospital leadership.
CONCLUSION: Implementing a successful THN program is possible in the ED setting, and individual hospital emergency departments seeking to build their own program may benefit from our report.
Copyright © 2020 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32690447     DOI: 10.1016/j.japh.2020.06.017

Source DB:  PubMed          Journal:  J Am Pharm Assoc (2003)        ISSN: 1086-5802


  3 in total

1.  Evaluating disparities in prescribing of naloxone after emergency department treatment of opioid overdose.

Authors:  Scott G Weiner; Aleta D Carroll; Nicholas M Brisbon; Claudia P Rodriguez; Charles Covahey; Erin J Stringfellow; Catherine DiGennaro; Mohammad S Jalali; Sarah E Wakeman
Journal:  J Subst Abuse Treat       Date:  2022-04-30

2.  Increasing Naloxone Prescribing in the Emergency Department Through Education and Electronic Medical Record Work-Aids.

Authors:  Mary Funke; Marcus C Kaplan; Holly Glover; Nicole Schramm-Sapyta; Andrew Muzyk; Jennifer Mando-Vandrick; Alexander Gordee; Maragatha Kuchibhatla; Emily Sterrett; Stephanie A Eucker
Journal:  Jt Comm J Qual Patient Saf       Date:  2021-03-06

3.  Hospital Care for Opioid use in Illinois, 2016-2019.

Authors:  Joe Feinglass; Jessica Ann Wang; Jiancheng Ye; Robert Tessier; Howard Kim
Journal:  J Behav Health Serv Res       Date:  2021-01-27       Impact factor: 1.505

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.